Household & Personal Products

BellRing Brands’ stock dips 61% from its 52‑week high as investors await new guidance amid a quiet market period.

CV Sciences Inc. sees volatile OTC stock, blending consumer personal‑care and specialty pharma; investors watch its low‑priced, loss‑bearing outlook.

Bonk Inc. shifts 51% of fees to BNKK token buy‑backs, boosting supply control and liquidity while launching a regulated ETP on SIX Swiss to attract institutional investors.

Explore Kenvue Inc.’s 2025 stock performance, valuation metrics and growth strategy, and discover why investors watch its consumer health dynamics.

How Kenvue’s stock surged on Nov 23 amid takeover whispers – explore the market reaction, key analysts’ insights, and what this could mean for investors.

Discover how Cannara Biotech’s record 32% revenue jump and first‑ever positive earnings are reshaping Canada’s medical cannabis market and boosting investor upside.

LiveWire Ergogenics faces steep financial struggles as a niche energy‑supplement brand in the competitive personal‑care market. Explore its challenges and potential paths to stability.

Adia Nutrition expands from probiotic staples to regenerative medicine, filing a new patent and delivering transparent Q2 results to boost investor confidence.

DSwiss Inc: Health‑beauty reach vs. alarmingly low stock, negative P/E and $6.6M cap—why investors worry about its sustainability.

Discover why Energizer Holdings’ stagnant momentum and lack of innovation risk turning investors into valuation traps, and what actions could revive its stock.